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Abstract
Background:  Increased spasms in spinal cord injury (SCI) patients, whose spasticity was
previously well controlled with intrathecal baclofen therapy, are due to (in order of frequency) drug
tolerance, increased stimulus, low reservoir volume, catheter malfunction, disease progression,
human error, and pump mechanical failure. We present a SCI patient, in whom bladder calculi acted
as red herring for increased spasticity whereas the real cause was spontaneous extrusion of
catheter from intrathecal space.
Case Presentation: A 44-year-old male sustained a fracture of C5/6 and incomplete tetraplegia
at C-8 level. Medtronic Synchromed pump for intrathecal baclofen therapy was implanted 13
months later to control severe spasticity. The tip of catheter was placed at T-10 level. The initial
dose of baclofen was 300 micrograms/day of baclofen, administered by a simple continuous
infusion. During a nine-month period, he required increasing doses of baclofen (875 micrograms/
day) to control spasticity. X-ray of abdomen showed multiple radio opaque shadows in the region
of urinary bladder. No malfunction of the pump was detected. Therefore, increased spasticity was
attributed to bladder stones. Electrohydraulic lithotripsy of bladder stones was carried out
successfully. Even after removal of bladder stones, this patient required further increases in the
dose of intrathecal baclofen (950, 1050, 1200 and then 1300 micrograms/day). Careful evaluation
of pump-catheter system revealed that the catheter had extruded spontaneously and was lying in
the paraspinal space at L-4, where the catheter had been anchored before it entered the
subarachnoid space. A new catheter was passed into the subarachnoid space and the tip of catheter
was located at T-8 level. The dose of intrathecal baclofen was decreased to 300 micrograms/day.
Conclusion: Vesical calculi acted as red herring for resurgence of spasticity. The real cause for
increased spasms was spontaneous extrusion of whole length of catheter from subarachnoid space.
Repeated bending forwards and straightening of torso for pressure relief and during transfers from
wheel chair probably contributed to spontaneous extrusion of catheter from spinal canal in this
patient.
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Background
Increased spasms in spinal cord injury (SCI) patients,
whose spasticity was previously well controlled with in-
trathecal baclofen therapy, are due to (in order of frequen-
cy) drug tolerance, increased stimulus, low reservoir
volume, catheter malfunction, disease progression, hu-
man error and pump mechanical failure. [1]. The frequen-
cy of complications after intrathecal baclofen therapy was
0.014 monthly, often due to catheter problems as noted
in 79 patients with a mean observation period of 34
months. [2]. Catheter failure was a common cause of in-
trathecal drug delivery problems and could be difficult to
diagnose. [3,4]. Catheter dislodgement can happen any
time after implantation of pump and catheter-o-gram will
confirm extravasation of contrast at the site of disconnec-
tion. (Figure 1). We present a spinal cord injury patient, in
whom bladder calculi acted as red herring for resurgence
of spasticity whereas the real cause for recurrence of
spasms was spontaneous extrusion of catheter from in-
trathecal space, a complication which has not been de-
scribed in medical literature (PubMed).
Case Presentation
A 44-year-old male sustained rupture of aorta, fracture of
both tibiae, fracture of C5/6 in a traffic accident. He un-
derwent thoracotomy and repair of transected aorta. Inter-
nal fixation and fusion of cervical spine was done at C-5/
C-6 level. He had developed incomplete tetraplegia (ASIA
scale D) at C-8 level. He was transferred to spinal injuries
centre thirteen months later. By then he had developed se-
vere spasticity of lower limbs.
Implantation of Medtronic Synchromed EL 8626-18
pump for intrathecal baclofen therapy was carried out.
The tip of catheter was placed at T-10 level in subarach-
noid space. The initial dose of baclofen was 300
micrograms/day, administered by a simple continuous in-
fusion. This patient required gradual increase in the dose
of baclofen to control spasticity. Intravenous urography,
performed ten weeks later, showed both kidneys excreting
contrast promptly. There was no hydronephrosis. The tip
Figure 1
Catheter-o-gram in a 49-year-old female patient with heredi-
tary spastic paraparesis and implantation of Medtronic pump 
for intrathecal baclofen therapy: Discontinuity/fracture of the 
catheter adjacent to the body of L-3 on the right.
Figure 2
Five minutes film of intravenous urography, performed on 
day 487, shows good excretion of contrast by both kidneys. 
There is no hydronephrosis. The catheter is seen in the spi-
nal canal. The tip of the catheter is located at T-10 level. 
There is no kink or dislodgement of catheter.BMC Urology 2003, 3 http://www.biomedcentral.com/1471-2490/3/3
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of catheter, for intrathecal administration of baclofen, was
seen at T-10 level. (Figure 2). The presence of radio
opaque shadows in the region of urinary bladder was not
noticed.
Over the next six months, this patient required increasing
amounts of baclofen ((875 micrograms/day) to control
spasms. The pump had been functioning satisfactorily
during this period. There was no pump stall. We did not
observe any discrepancy between telemetry reading and
the volume of fluid aspirated from the reservoir before re-
filling the pump. No noxious lesion such as kidney stones,
which could account for increased spasticity, was detected
in this patient. [5]
Nine months after implantation of baclofen pump, X-ray
of abdomen showed multiple radio opaque shadows in
the region of urinary bladder. (Figure 3). Flexible cystos-
copy confirmed the presence of vesical calculi. (Figure 4).
As there was no pump stall and no discrepancy was ob-
served between telemetric reading and the volume of fluid
in the reservoir as checked by aspiration, increased spas-
ticity was attributed to bladder stones. Electrohydraulic
lithotripsy of bladder stones was carried out successfully.
Even after removal of bladder stones, this patient required
increasing dose of intrathecal baclofen. (Figure 5). When
the dose of intrathecal baclofen was increased, the spasms
were controlled satisfactorily albeit only for a short peri-
od. Prompt relief of spasticity, as observed by the patient
when the dose of intrathecal baclofen was increased, led
us to believe that the patient was perhaps developing tol-
erance to baclofen. In retrospect, we realise that we should
have thoroughly examined the pump and the catheter sys-
tem for any fault before increasing the dose of intrathecal
baclofen.
X-ray of abdomen was taken seven weeks later to look for
any dislodgement of catheter. Careful evaluation of
pump-catheter system revealed that the catheter had ex-
truded spontaneously from intrathecal space. The tip of
catheter, which was placed at T-10 level, had extruded all
the way down to paraspinal space at L-4, which was the
site of entry of the catheter into subarachnoid space. (Fig-
ure 6). MRI scan showed no evidence of collection of cer-
ebrospinal fluid in paravertebral soft tissue. CT scan
showed the tip of catheter coiled superficially within the
right longissimus lumborum muscle. (Figure 7). On ex-
ploration, the catheter was found coiled under the sheath
of paraspinal muscle. A new catheter was passed into the
Figure 3
X-ray abdomen, taken on day 689, shows multiple radio 
opaque shadows in the region of urinary bladder. We failed 
to notice the absence of catheter in the spinal canal and coil-
ing of catheter in paravertebral region at L-4 level.
Figure 4
Flexible cystoscopy showed multiple calculi in the urinary 
bladder. Bladder stones acted as red herring for resurgence 
of spasticity whereas the true reason was spontaneous 
extrusion of catheter from the spinal canal.BMC Urology 2003, 3 http://www.biomedcentral.com/1471-2490/3/3
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Table 1: Chronology of clinical events, dose of intrathecal baclofen, location of tip of catheter for delivery of baclofen and presence of 
bladder stones
Days Clinical event Dose of intrathecal 
baclofen Micro-grams/day
Location of catheter tip Bladder stones
Day 0 Road traffic accident Spinal cord injury - - -
412 Implantation of Medtronic Synchromed 
EL pump
300 T-10 -
487 Intravenous urography 530 T-10 Yes*
500 Back ache 575 - -
689 X-ray of abdomen 875 The catheter has come out of the spinal 
canal. The catheter is coiled in the par-
aspinal space at L-4 level.*
Yes
700 Cystoscopy and electrohydraulic lithot-
ripsy of vesical calculi
875 - -
738 X-ray of abdomen 1300 The catheter has come out of the spinal 
canal. The catheter is coiled in the par-
aspinal space at L-4 level.
No
759 MRI and CT scan of lumbar spine 1300 No CSF collection in paravertebral soft 
tissue. The tip of catheter is coiled 
superficially within right longissimus 
lumborum muscle.
No
763 Exploration revealed the catheter lying 
under the sheath of paraspinal muscle.
300 A new catheter was passed into the 
subarachnoid space and the tip of cath-
eter was located at T-8 level, which was 
confirmed by X-ray screening.
No
* These observations were made in retrospect after seeing the X-ray, which was taken on day 738.
Figure 5
Chart shows dose of baclofen administered by simple, continuous infusion by Medtronic Synchromed pump. The patient 
required increasing dose of baclofen from 300 micrograms/day on day 412 to 1300 micrograms/day on day 738.
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subarachnoid space and the tip of catheter was located at
T-8 level, which was confirmed by X-ray screening. Both
tubes were connected and stabilised. The dose of intrath-
ecal baclofen was decreased to 300 micrograms/day.
Chronology of clinical events, dose of intrathecal ba-
clofen, location of tip of catheter for delivery of baclofen
and presence of bladder stones are summarised in Table 1.
Discussion
We report spontaneous extrusion of catheter from the spi-
nal canal, which is a very unusual complication of intrath-
ecal baclofen therapy. It is likely that repeated bending
forwards and straightening of torso for pressure relief and
during transfers from wheelchair, contributed to extrusion
of catheter from the spinal canal in this patient. After ex-
truding out of the spinal canal, the catheter got coiled in
paravertebral space, where the catheter had been
anchored firmly to intermuscular septum. Spontaneous
extrusion of catheter from the spinal canal is unlikely to
occur in profoundly disabled individuals, who do not
actively move their trunk. For example, there may be indi-
viduals with advanced multiple sclerosis, who are con-
Figure 6
X-ray of abdomen, (close-up view of lumbar spine) which 
was taken on day 738 shows the catheter has come out of 
the spinal canal. The catheter is coiled in the paraspinal space 
at L-4 level.
Figure 7
CT of lumbar spine performed on day 759, shows the tip of 
catheter coiled superficially within the right longissimus lum-
borum muscle. Baclofen pump is located in the anterior 
abdominal wall.
Figure 8
X-ray of pelvis taken on day 487 shows vesical calculi. When 
this X-ray was taken, the patient had adequate control of 
spasticity despite the presence of bladder stones because the 
pump was delivering baclofen satisfactorily with the tip of 
catheter located at T-10 level.BMC Urology 2003, 3 http://www.biomedcentral.com/1471-2490/3/3
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fined to the chair and who do not have the ability to bend
forwards and then straighten the torso for pressure relief
or, perform unassisted transfers from the wheel chair to
bed, toilet seat, or car. These patients are unlikely to devel-
op extrusion of catheter from spinal canal if they undergo
implantation of Medtronic pump for intrathecal baclofen
therapy.
Abrupt withdrawal of intrathecal baclofen therapy can re-
sult in a life-threatening syndrome (high fever, altered
mental status, profound muscular rigidity that may some-
times progress to fatal rhabdomyolysis). The intrathecal
baclofen withdrawal syndrome is clinically and patho-
physiologically distinct from autonomic dysreflexia, ma-
lignant hyperthermia, and neuroleptic-malignant
syndrome. [6]. This patient did not develop intrathecal
baclofen withdrawal syndrome at any stage. Probably, the
catheter came out of thecal space very gradually over a pe-
riod. Even when the catheter was extruded completely
from thecal space, it is likely that a fibrous channel existed
between the tip of the catheter and thecal space, which
provided an entry path to the infused drug to reach thecal
space. This would explain prompt relief of spasticity when
the dose of intrathecal baclofen was increased.
The tip of catheter was placed at T-8 level during the sec-
ond operation. Initially, the tip of catheter was located at
T-10 level. Burns and Meythaler [7] emphasised the
importance of the level of intrathecal catheter placement
to achieve satisfactory control of spasticity. Placement of
the tip of the intrathecal catheter at the T-6 / T-7 level was
associated with greater relief of upper-extremity spasticity
without loss of effect on the lower extremities. The mean
dosages of baclofen in children with spastic tetraparesis,
in whom intrathecal catheter was placed at the T-6 / T-7
level with fluoroscopic guidance, were lower compared
with mean dosages when the catheter tip had been placed
at the T-11 / T-12 level. No morbidity related to the more
rostral location of the catheter was observed in the chil-
dren, in whom the catheter tip had been placed at the T-6
/ T-7 level. [8]
This case illustrates that catheter-pump malfunction
should be excluded before ascribing resurgence of spastic-
ity to drug tolerance, or other co-existing conditions such
as bladder stones, particularly in SCI patients, whose
spasms had been well controlled previously with intrath-
ecal baclofen therapy. Vesical calculi acted as red herring
for recurrence of spasms in this patient. In retrospect, we
observed that vesical calculi were present even in the X-
rays taken on day 487 when the patient had adequate con-
trol of spasticity and the pump was delivering baclofen
satisfactorily with the tip of catheter located at T-10 level.
(Figure 8). Had the X-ray taken on day 689 been available
in an easily retrievable format for repeated viewing by dif-
ferent health professionals, it is likely that at least one of
us would have noticed spontaneous extrusion of catheter
from the spinal canal and we would have implemented
corrective measures expeditiously.
It is possible that some physicians might have encoun-
tered similar mishap after implantation of baclofen
pump, but have not published the adverse events for fear
of recrimination. We favour voluntary reporting and
dissemination of information on adverse events related to
clinical procedures and medical implants [9–11]. Quite
often, mishaps occur due to system errors and therefore,
apportioning blame to individual health professionals
should be avoided. A joint team approach by health pro-
fessionals belonging to various medical disciplines, which
is strengthened by frequent, informal and honest discus-
sions of a patient's clinical condition, is likely to reduce
delays in diagnosis and medical errors in spinal cord inju-
ry patients.
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